Chase Medical
Founded Year
1995Stage
Series D | AliveTotal Raised
$17.1MLast Raised
$8.1M | 13 yrs agoAbout Chase Medical
Chase Medical is developing medical technology for treating congestive heart failure. Chase Medical is developing a device called the Mannequin which aims to help the heart maintain its shape while going through reconstruction of the left ventricle.
Chase Medical Headquarter Location
1876 Firman Drive
Richardson, Texas, 75081,
United States
972-783-0644
Chase Medical Patents
Chase Medical has filed 6 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/15/2004 | 8/10/2010 | Health informatics, Electronic health records, Telehealth, Pseudoscience, Health standards | Grant |
Application Date | 3/15/2004 |
|---|---|
Grant Date | 8/10/2010 |
Title | |
Related Topics | Health informatics, Electronic health records, Telehealth, Pseudoscience, Health standards |
Status | Grant |
Chase Medical Web Traffic
Chase Medical Rank
When was Chase Medical founded?
Chase Medical was founded in 1995.
Where is Chase Medical's headquarters?
Chase Medical's headquarters is located at 1876 Firman Drive, Richardson.
What is Chase Medical's latest funding round?
Chase Medical's latest funding round is Series D.
How much did Chase Medical raise?
Chase Medical raised a total of $17.1M.
Who are the investors of Chase Medical?
Investors of Chase Medical include Capital Southwest, First Capital Group and Red River Ventures.
Who are Chase Medical's competitors?
Competitors of Chase Medical include Respicardia, Cayenne Medical, CardioKinetix, CircuLite, MiCardia and 13 more.
You May Also Like
CardioKinetix develops a percutaneous treatment for patients with left ventricular dilation after an anterior myocardial infarction (MI). The implantable device, called the PARACHUTE is a partitioning membrane deployed within the compromised ventricle. The PARACHUTE partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, and decreases the overall volume. Options for patients whose ventricle has enlarged are limited, with most on medical therapy and/or a cardiac resynchronization device that only benefits heart failure patients with a specific EKG pattern.
Cardiac Power is a non-blood-contacting left ventricular assist device for the treatment of congestive heart failure
CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.
Bio Control Medical offers implantable devices for the treatment of incontinence and congestive heart failure.
Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of congestive heart failure.
Ancora Heart is developing a therapy to address heart failure. Ancora Heart's AccuCinch Ventricular Repair System is a minimally invasive investigational treatment for heart failure and functional mitral regurgitation (FMR).
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.